Mark Hallett MDPast-President, International Federation of Clinical Neurophysiology; Senior Investigator, Human Motor Control Section, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland
Dr. Hallett is the current Past-President of the International Federation of Clinical Neurophysiology. Since 1984, he has been at the National Institute of Neurological Disorders and Stroke, where he heads the Human Motor Control Section. His research work mainly deals with principles of motor control and the pathophysiology of movement disorders.
Dr. Hallett is past President of the American Association of Neuromuscular and Electrodiagnostic Medicine and the International Parkinson and Movement Disorder Society, and past Vice-President of the American Academy of Neurology. He is past Editor-in-Chief of Clinical Neurophysiology and past Associate Editor of Brain. He has served, and is now serving, on many editorial boards. He is the recipient of many honors and has delivered many named lectures worldwide.
Dr. Hallett obtained his medical degree from Harvard Medical School, interned at the Peter Bent Brigham Hospital, and trained in neurology at Massachusetts General Hospital. He completed fellowship training in neurophysiology at the National Institutes of Health and at the Institute of Psychiatry in London. From 1976 to 1984, Dr. Hallett was the Chief of the Clinical Neurophysiology Laboratory at the Brigham and Women's Hospital. Before he left Boston, he was Associate Professor of Neurology at Harvard Medical School.
Past-President, International Federation of Clinical Neurophysiology;
Chief, Human Motor Control Section, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland
MD: Harvard Medical School, Boston, Massachusetts
D.M.(hon): University of Hamburg, Hamburg, Germany
Fellowship (neurophysiology): National Institutes of Health, Bethesda, Maryland
Fellowship (neurophysiology): Institute of Psychiatry, London, UK
Principles of motor control; pathophysiology of movement disorders
Mark Hallett, MD serves on the Advisory Boards of Cala Health and Brainsway, and has received grant support from Medtronic, Inc, Merz and Allergan.
Recent Contributions to PracticeUpdate:
- SNAREopathies: Diversity in Mechanisms and Symptoms
- 2019 Top Stories in Neurology: Functional Neurological Disorders Can Be Treated
- AAN 2019: Recommendations From Dr. Mark Hallett
- High Prevalence of Neutralizing Antibodies After Long-Term Botulinum Neurotoxin Therapy
- 2018 Top Stories in Neurology: Gene Therapy
- Zonisamide as an Adjunct to Levodopa for DLB Parkinsonism
- 2017 Top Stories in Neurology: Look Out for Toxic Antibodies
- Stereotactic Radiosurgery for Essential Tremor
- 2016 Top Stories in Neurology: Parkinson's Disease
- Hypertension and Increased Mortality in Children With Arterial Ischemic Stroke